Volume 31, Issue 145 (March & April 2023)                   J Adv Med Biomed Res 2023, 31(145): 177-183 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini A, Alavi M S, Mohammadi S, Tayarani Najjaran Z, Rajabian A. Portulaca oleracea Protects H9c2 Cardiomyocytes Against Doxorubicin-Induced Toxicity by Inhibition of Oxidative Stress and Apoptosis. J Adv Med Biomed Res 2023; 31 (145) :177-183
URL: http://journal.zums.ac.ir/article-1-6698-en.html
Portulaca oleracea Protects H9c2 Cardiomyocytes Against Doxorubicin-Induced Toxicity by Inhibition of Oxidative Stress and Apoptosis
Azar Hosseini1 , Mohaddeseh Sadat Alavi1 , Soroush Mohammadi2 , Zahra Tayarani Najjaran3 , Arezoo Rajabian * 4
1- Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
2- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
3- Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4- Dept. of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , Rajabianar@mums.ac.ir
Abstract:   (11018 Views)

Background and Objective: Doxorubicin as an effective chemotherapeutic agent is frequently used in various cancers. Nowadays, the application of doxorubicin is limited due to its cardiotoxic effects. The important mechanism which is involved in the cardiac injury of doxorubicin is the generation of reactive oxygen species; therefore antioxidant compounds may reduce cardiotoxicity. In the present study, we evaluated the protective effects of Portulaca oleracea extract against doxorubicin-induced damage in cardiomyocytes cell line H9c2.
Materials and Methods: The H9c2 cells were pre-treated for 2h with different concentrations of extract (12-400µg/ml) or resveratrol (50µM, positive control), and then doxorubicin was added for 24h. Afterward, the cell viability, and parameters of oxidative stress including lipid peroxidation and reactive oxygen species (ROS) generation, and also apoptosis rate, were measured.
Results: The results revealed that doxorubicin extremely decreased cell viability via increasing malondialdehyde, ROS, and apoptotic cells. The extract could reverse doxorubicin-induced cardiotoxicity through anti-oxidant activity.
Conclusion: In conclusion, we witnessed that P. oleracea has protective effect against doxorubicin-caused cardiomyocytes damage.

Keywords: Cardioprotective agents, Doxorubicin, Cardiomyocytes, Portulaca oleracea
Full-Text [PDF 648 kb]   (7879 Downloads) |   |   Full-Text (HTML)  (758 Views)  

✅In conclusion, we witnessed that P. oleracea has protective effect against doxorubicin-caused cardiomyocytes damage.


Type of Study: Original Article | Subject: Pharmacology
Received: 2022/02/4 | Accepted: 2022/08/6 | Published: 2023/03/13
References
1. Damiani RM, Moura DJ, Viau CM, Caceres RA, Henriques JAP, Saffi J. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. Arch Toxicol. 2016;90(9):2063-76. [DOI:10.1007/s00204-016-1759-y] [PMID]
2. Raj S, Franco VI, Lipshultz SE. Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment. Curr Treat Option Cardiovasc Med. 2014;16(6):315. [DOI:10.1007/s11936-014-0315-4] [PMID]
3. Csapo M, Lazar L. Chemotherapy induced cardiotoxicity: Pathophysiology and prevention. Clujul Med. 2014;87(3):135-42. [DOI:10.15386/cjmed-339] [PMID] [PMCID]
4. Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735. [DOI:10.1038/srep44735] [PMID] [PMCID]
5. QuanJun Y, GenJin Y, LiLi W, et al. Protective effects of dexrazoxane against doxorubicin-induced cardiotoxicity: A metabolomic study. PloS one. 2017;12(1):e0169567. [DOI:10.1371/journal.pone.0169567] [PMID] [PMCID]
6. Dallons M, Schepkens C, Dupuis A, Tagliatti V, Colet JM. New insights about doxorubicin-induced toxicity to cardiomyoblast-derived H9C2 cells and dexrazoxane cytoprotective effect: contribution of in vitro (1)H-NMR metabonomics. Front Pharmacol. 2020;11:79. [DOI:10.3389/fphar.2020.00079] [PMID] [PMCID]
7. Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015;5(2):84.
8. Hosseini A, Sahebkar A. Reversal of doxorubicin-induced cardiotoxicity by using phytotherapy: a review. J Pharmacopuncture. 2017;20(4):243.
9. Sangweni NF, Moremane M, Riedel S, et al. The prophylactic effect of pinocembrin against doxorubicin-induced cardiotoxicity in an in vitro H9c2 cell model. Front Pharmacol. 2020;11:1172. [DOI:10.3389/fphar.2020.01172] [PMID] [PMCID]
10. Elkhayat ES, Ibrahim SR, Aziz MA. Portulene, a new diterpene from Portulaca oleracea L. J Asian Nat Product Res. 2008;10(11):1039-43. [DOI:10.1080/10286020802320590] [PMID]
11. Iranshahy M, Javadi B, Iranshahi M, et al. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol. 2017;205:158-72. [DOI:10.1016/j.jep.2017.05.004] [PMID]
12. Khazdair MR, Saadat S, Aslani MR, Shakeri F, Boskabady MH. Experimental and clinical studies on the effects of Portulaca oleracea L. and its constituents on respiratory, allergic, and immunologic disorders, a review. Phytother Res. 2021;35(12):6813-42. [DOI:10.1002/ptr.7268] [PMID]
13. Shafi S, Tabassum N. Acute oral toxicity and hypoglycaemic study of ethanolic extract of portulaca oleracea (whole plant) in swiss albino mice. Int J Pharm Pharm Sci. 2013; 5(4):389-93.
14. Radhakrishnan R, Zakaria M, Islam M, et al. Neuropharmacological actions of Portulaca oleraceae L v. sativa (Hawk). J Ethnopharmacol. 2001;76(2):171-6. [DOI:10.1016/S0378-8741(01)00230-6] [PMID]
15. Lim YY, Quah EP. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem. 2007;103(3):734-40. [DOI:10.1016/j.foodchem.2006.09.025]
16. Baradaran Rahimi V, Rakhshandeh H, Raucci F, et al. Anti-inflammatory and anti-oxidant activity of Portulaca oleracea extract on LPS-induced rat lung injury. Molecules. 2019;24(1):139. [DOI:10.3390/molecules24010139] [PMID] [PMCID]
17. Zhu H, Wang Y, Liu Y, Xia Y, Tang T. Analysis of flavonoids in Portulaca oleracea L. by UV-vis spectrophotometry with comparative study on different extraction technologies. Food Analyt Method. 2010;3(2):90-7. [DOI:10.1007/s12161-009-9091-2]
18. Subpiramaniyam S. Portulaca oleracea L. for phytoremediation and biomonitoring in metal-contaminated environments. Chemosphere. 2021;280:130784. [DOI:10.1016/j.chemosphere.2021.130784] [PMID]
19. Chen JY, Hu RY, Chou HC. Quercetin-induced cardioprotection against doxorubicin cytotoxicity. J Biomed Sci. 2013;20(1):95. [DOI:10.1186/1423-0127-20-95] [PMID] [PMCID]
20. Dong Q, Chen L, Lu Q, et al. Quercetin attenuates doxorubicin cardiotoxicity by modulating B mi‐1 expression. Br J Pharmacol. 2014;171(19):4440-54. [DOI:10.1111/bph.12795] [PMID] [PMCID]
21. Yu X, Cui L, Zhang Z, Zhao Q, Li S. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis. Acta Biochim Biophys Sin. 2013;45(10):817-26. [DOI:10.1093/abbs/gmt082] [PMID]
22. Xiao J, Sun GB, Sun B, et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicol. 2012;292(1):53-62. [DOI:10.1016/j.tox.2011.11.018] [PMID]
23. Zare MFR, Rakhshan K, Aboutaleb N, et al. Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats. Life Sci. 2019;232:116623. [DOI:10.1016/j.lfs.2019.116623] [PMID]
24. Yu W, Sun H, Zha W, et al. Apigenin attenuates adriamycin-induced cardiomyocyte apoptosis via the PI3K/AKT/mTOR pathway. Evid Based Complement Alternat Med. 2017;2017. [DOI:10.1155/2017/2590676] [PMID] [PMCID]
25. Arafa MH, Mohammad NS, Atteia HH, Abd-Elaziz HR. Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. J Physiol Biochem. 2014;70(3):701-11. [DOI:10.1007/s13105-014-0339-y] [PMID]
26. Lou Y, Wang Z, Xu Y, et al. Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. Int J Molec Med. 2015;36(3):873-80. [DOI:10.3892/ijmm.2015.2291] [PMID]
27. Shojaee S, Parhiz H, Eshaghi A, et al. In vitro protective effects of Scutellaria litwinowii root extract against H2O2-induced DNA damage and cytotoxicity. J Complement Integrat Med. 2014;11(2):121-7. [DOI:10.1515/jcim-2014-0009] [PMID]
28. Hosseini A, Rajabian A. Protective effect of Rheum turkestanikum root against doxorubicin-induced toxicity in H9c2 cells. Revista Brasileira de Farmacognosia. 2016;26(3):347-51. [DOI:10.1016/j.bjp.2016.02.004]
29. Mousavi SH, Hosseini A, Bakhtiari E, Rakhshandeh H. Capparis spinosa reduces Doxorubicin-induced cardio-toxicity in cardiomyoblast cells. Avicenna J Phytomed. 2016;6(5):488.
30. Sadeghnia HR, Rajabian A, Ghorbani A, Moradzadeh M, Hosseini A. Effects of standardized extract of Ferula gummosa root on glutamate-induced neurotoxicity. Folia neuropathologica. 2017;55(4):340-6. [DOI:10.5114/fn.2017.72399] [PMID]
31. Rajabian A, Sadeghnia HR, Moradzadeh M, Hosseini A. Rheum turkestanicum reduces glutamate toxicity in PC12 and N2a cell lines. Folia neuropathologica. 2018;56(4):354-61. [DOI:10.5114/fn.2018.80869] [PMID]
32. Sun S, Wang K, Lei H, et al. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Progress Neuro Psychopharmacol Biol Psychiatr. 2014;49:1-6. [DOI:10.1016/j.pnpbp.2013.11.005] [PMID]
33. Renu K, Abilash V, PB TP, Arunachalam S. Molecular mechanism of doxorubicin-induced cardiomyopathy-An update. Europ J Pharmacol. 2018;818:241-53. [DOI:10.1016/j.ejphar.2017.10.043] [PMID]
34. Deres P, Halmosi R, Toth A, et al. Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J Cardiovasc Pharmacol. 2005;45(1):36-43. [DOI:10.1097/00005344-200501000-00007] [PMID]
35. Liu J, Pei M, Zheng C, et al. A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets. Evid Based Complement Alternat Med. 2013;2013. [DOI:10.1155/2013/938764] [PMID] [PMCID]
36. Farkhondeh T, Samarghandian S, Azimi-Nezhad M, Hozeifi S. The hepato-protective effects of Portulaca oleracea L. extract: Review. Curr Drug Discover Technol. 2019;16(2):122-6. [DOI:10.2174/1570163815666180330142724] [PMID]
37. Qiao JY, Li HW, Liu FG, et al. Effects of Portulaca Oleracea extract on acute alcoholic liver injury of rats. Molecules. 2019;24(16):2887. [DOI:10.3390/molecules24162887] [PMID] [PMCID]
38. E Abdel Moneim A. The neuroprotective effects of purslane (Portulaca oleracea) on rotenone-induced biochemical changes and apoptosis in brain of rat. CNS Neurol Disord Drug Targets. 2013;12(6):830-41. [DOI:10.2174/18715273113129990081] [PMID]
39. Pakdel R, Vatanchian M, Niazmand S, et al. Comparing the effects of Portulaca oleracea seed hydro-alcoholic extract, valsartan, and vitamin E on hemodynamic changes, oxidative stress parameters and cardiac hypertrophy in thyrotoxic rats. Drug Chem Toxicol. 2019:1-8. [DOI:10.1080/01480545.2019.1651330] [PMID]
40. Khodadadi H, Pakdel R, Khazaei M, Niazmand S, Bavarsad K, Hadjzadeh MA-R. A comparison of the effects of Portulaca oleracea seeds hydro-alcoholic extract and Vitamin C on biochemical, hemodynamic and functional parameters in cardiac tissue of rats with subclinical hyperthyroidism. Avicenna J Phytomed. 2018;8(2):161.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb